Literature DB >> 3734780

Involvement of organic molybdenum compounds in the interaction between copper, molybdenum, and sulfur.

J D Allen, J M Gawthorne.   

Abstract

The effect on Cu metabolism of two organic Mo compounds, cysteine-Mo (CM) and cysteine-Mo-S (CMS), and of an inorganic compound, tetrathiomolybdate (TTM), was investigated in sheep. Intravenous administration of CMS or TTM increased total plasma Cu concentrations and promoted the appearance of trichloroacetic acid (TCA)-insoluble Cu in plasma. Plasma Mo was increased by both compounds. Column chromatography of plasma showed that CMS caused the accumulation of TCA-insoluble Cu in high-MW fractions, whereas TTM increased the Cu content of low-MW fractions, mainly albumin. CMS and TTM increased the concentration of Cu and Mo in kidney. In liver, Mo concentrations were elevated by both CMS and TTM, and Cu concentrations were reduced by TTM when it was given at a low dose rate. The subcellular distribution of Cu and Mo in liver and kidney was investigated. The findings are discussed in relation to the proposal that Mo-containing, organic compounds are intermediaries in the interaction between Cu, Mo, and S in ruminants.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734780     DOI: 10.1016/0162-0134(86)80011-3

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Survey of the status of copper, interacting minerals, and vitamin E levels in the livers of sheep in Ontario.

Authors:  Paula I Menzies; Herman Boermans; Brent Hoff; Tiffany Durzi; Lisa Langs
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

2.  Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.

Authors:  Kyu Kwang Kim; Alex Han; Naohiro Yano; Jennifer R Ribeiro; Elizabeth Lokich; Rakesh K Singh; Richard G Moore
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.